Top Industry Leaders in the Costochondritis Market
Latestย Costochondritisย Companiesย Updates:
Johnson & Johnson's Ethicon unit launched the Enseal X1 Straight Jaw Tissue Sealer in April 2022. While not directly applicable to Costochondritis, this advanced device highlights J&J's continued investment in minimally invasive surgical tools, which could potentially be used in future surgical treatments for severe Costochondritis cases.
Stryker received FDA approval for BoTOXยฎ for Glabellar Lines in August 2023. Again, not directly related to Costochondritis, this approval showcases the expanding applications of BoTOXยฎ for pain management, potentially opening doors for future research on its use for Costochondritis-related pain.
List ofย Costochondritisย companies in the market:
- KemPharm
- GlaxoSmithKline plc
- Biovail Corporation
- Aurobindo Pharma
- Pfizer Inc
- Recro Pharma Inc
- LUPIN
- Bausch Health Companies Inc
- Avenue Therapeutics